Drug Trial Radar · NCT02736656
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,400
Planned (sponsor's estimate)
Start
Feb 2, 2016
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Supernus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 13, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 4 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients
Conditions
- Attention-Deficit/Hyperactivity Disorder
Interventions
SPN-812Drug
Cohort 'A': Children 6-11 yrs of age take 100-400mg SPN-812 once daily by mouth and adolescents 12-17 yrs of age take 100-600mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'A' are given a choice to extend their participation in the study every 6 months for up to 72 months. Cohort 'B': Pre-school-age children 4-5 yrs of age take 100mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'B' will be treated with 100 mg SPN-812 (100 mg capsule) for up to 6 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse eventsTime frame: up to 72 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research Group
Little Rock, Arkansas
Alliance for Wellness dba Alliance for Research
Long Beach, California
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado
Meridien Research at Florida Clinical Research Center
Bradenton, Florida
Sarkis Clinical Trials
Gainesville, Florida
Indago Research & Health Center, Inc.
Hialeah, Florida
Florida Clinical Research Center, LLC.
Maitland, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
IPS Research
Oklahoma City, Oklahoma
Paradigm Research Professionals
Oklahoma City, Oklahoma
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
CNS Healthcare
Memphis, Tennessee
Bayou City Research Corporation
Houston, Texas
Road Runner Research
San Antonio, Texas
Ericksen Research & Development
Clinton, Utah
Northwest Clinical Trials
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.